CY2092B1 - Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents - Google Patents

Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents

Info

Publication number
CY2092B1
CY2092B1 CY9800013A CY9800013A CY2092B1 CY 2092 B1 CY2092 B1 CY 2092B1 CY 9800013 A CY9800013 A CY 9800013A CY 9800013 A CY9800013 A CY 9800013A CY 2092 B1 CY2092 B1 CY 2092B1
Authority
CY
Cyprus
Prior art keywords
chem
formula
reaction product
alkyl
reacting
Prior art date
Application number
CY9800013A
Other languages
English (en)
Inventor
Douglas Patton Kjell
Fred Mason Perry
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CY2092B1 publication Critical patent/CY2092B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56—Radicals substituted by oxygen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Furan Compounds (AREA)
CY9800013A 1994-08-31 1998-06-18 Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents CY2092B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/298,636 US5631369A (en) 1994-08-31 1994-08-31 Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents

Publications (1)

Publication Number Publication Date
CY2092B1 true CY2092B1 (en) 2002-04-05

Family

ID=23151367

Family Applications (1)

Application Number Title Priority Date Filing Date
CY9800013A CY2092B1 (en) 1994-08-31 1998-06-18 Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents

Country Status (17)

Country Link
US (2) US5631369A (ko)
EP (1) EP0699672B1 (ko)
JP (1) JPH08119964A (ko)
KR (1) KR100359959B1 (ko)
AT (1) ATE165355T1 (ko)
BR (1) BR9503846A (ko)
CA (1) CA2157236A1 (ko)
CY (1) CY2092B1 (ko)
DE (1) DE69502152T2 (ko)
DK (1) DK0699672T3 (ko)
ES (1) ES2114721T3 (ko)
FI (1) FI114706B (ko)
GR (1) GR3026742T3 (ko)
HK (1) HK1006912A1 (ko)
HU (2) HU222121B1 (ko)
IL (1) IL115092A0 (ko)
TW (1) TW427975B (ko)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL333356A1 (en) * 1996-08-28 1999-12-06 Lilly Co Eli Amorphous benzothiophenes, methods of obtaining them and ways of their application
CA2231013A1 (en) * 1997-04-30 1998-10-30 Eli Lilly And Company Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceuticals
US7124425B1 (en) * 1999-03-08 2006-10-17 Immersion Entertainment, L.L.C. Audio/video system and method utilizing a head mounted apparatus with noise attenuation
WO2001023369A2 (en) * 1999-09-27 2001-04-05 Eli Lilly And Company Process for preparing benzoic acids
FR2817865B1 (fr) * 2000-12-11 2005-02-18 Sanofi Synthelabo Derive aminoalkoxybenzoyle sous forme de sel, son procede de preparation et son utilisation comme intermediaire de synthese
EP1546138B1 (en) 2002-09-30 2012-01-18 A/S GEA Farmaceutisk Fabrik Raloxifene l-lactate or a hemihydrate thereof, their uses, pharmaceutical compositions and preparation processes
US7012153B2 (en) * 2003-12-22 2006-03-14 Eli Lilly And Company Process for preparing benzoic acids
IN2014MN00380A (ko) 2006-06-30 2015-06-19 Iceutica Pty Ltd
CA2759125C (en) 2009-04-24 2017-08-15 Iceutica Pty Ltd A novel formulation of indomethacin
US9526734B2 (en) 2014-06-09 2016-12-27 Iceutica Pty Ltd. Formulation of meloxicam
KR102117214B1 (ko) 2020-03-26 2020-06-01 유지씨 주식회사 에어 리스 스프레이 건 용 도료 비산 방지 커버 하우징
KR102145873B1 (ko) 2020-06-10 2020-08-20 유지씨 주식회사 에어 리스 스프레이건 용 도료 비산 방지 커버 하우징 및 그 비산 방지 커버 하우징이 결합 된 고소작업대용 도색장치 및 그 비산 방지 커버 하우징이 결합 된 달비계용 도색 장치 및 그 비산 방지 커버 하우징이 결합 된 평면용 도색장치
KR102227020B1 (ko) 2020-12-18 2021-03-12 유지씨 주식회사 스프레이 건 용 도료 비산 방지 커버 하우징 결합체
KR102444617B1 (ko) 2021-05-28 2022-09-16 이다지 도장용 스프레이건의 비산방지장치
KR102607000B1 (ko) 2023-03-24 2023-11-29 이다지 도장용 스프레이 건의 비산방지장치

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3947470A (en) * 1974-06-20 1976-03-30 Smithkline Corporation Substituted benzofurans and benzothiophenes
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4358593A (en) * 1981-04-03 1982-11-09 Eli Lilly And Company Process for preparing 3-(4-aminoethoxybenzoyl)benzo[b]thiophenes
IL65379A0 (en) * 1981-04-03 1982-05-31 Lilly Co Eli Process for preparing acylated benzothiophenes
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
GB2097788B (en) * 1981-04-03 1985-04-24 Lilly Co Eli Benzothiophene compounds and process for preparing them
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US4656187A (en) * 1981-08-03 1987-04-07 Eli Lilly And Company Treatment of mammary cancer
CA2020887A1 (en) * 1989-07-28 1991-01-29 Michael Klaus Aromatic carboxylic amides

Also Published As

Publication number Publication date
HK1006912A1 (en) 1999-03-19
CA2157236A1 (en) 1996-03-01
FI114706B (fi) 2004-12-15
US5631369A (en) 1997-05-20
US5750688A (en) 1998-05-12
BR9503846A (pt) 1996-09-17
KR960007543A (ko) 1996-03-22
FI954067A (fi) 1996-03-01
ES2114721T3 (es) 1998-06-01
EP0699672B1 (en) 1998-04-22
DK0699672T3 (da) 1998-10-07
FI954067A0 (fi) 1995-08-30
TW427975B (en) 2001-04-01
EP0699672A1 (en) 1996-03-06
HU222121B1 (hu) 2003-04-28
DE69502152T2 (de) 1998-09-17
KR100359959B1 (ko) 2003-01-14
HU0003473D0 (ko) 1995-08-30
ATE165355T1 (de) 1998-05-15
GR3026742T3 (en) 1998-07-31
DE69502152D1 (de) 1998-05-28
IL115092A0 (en) 1995-12-08
HU9502537D0 (en) 1995-10-30
HUT73141A (en) 1996-06-28
JPH08119964A (ja) 1996-05-14

Similar Documents

Publication Publication Date Title
CY2092B1 (en) Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents
IL115335A0 (en) Naphthyl compounds intermediates processes compositions and methods
DE69411243D1 (de) Verfahren zur herstellung eines lignan-derivats
TW368497B (en) Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents
EP0094065B1 (en) 2-aminobenzoic acid derivatives, a process for their preparation and pharmaceutical compositions
CA2127292A1 (en) Process for producing hydroxyalkane carboxylic acid amides
KR20010005943A (ko) 0-(3-아미노-2-히드록시-프로필)-히드록심산할라이드의 제조방법
US4091095A (en) Phosphinyl compounds
US4960900A (en) Oxyimino derivatives of thiazole, method of preparation and use in therapy
ATE141583T1 (de) Alpha-methylencyclopentanon-derivate und verfahren zu ihrer herstellung
KR870007111A (ko) β-비스(알콕시이미노) 사이클로알킬렌 유도체의 제조방법
KR840001732B1 (ko) 폴리프레닐 카르복실산 아미드의 제조방법
GR3034636T3 (en) Antifoaming agents.
HU209295B (en) Process for producing amine-substituted terciary carbinol derivatives
EP0233512A1 (en) Cyclohexene carboxylic esters and amides as antidysrhythmic agents